𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Minocycline is not beneficial in a phenotypic mouse model of Huntington's disease

✍ Scribed by Elsa Diguet; Richard Rouland; François Tison

Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
69 KB
Volume
54
Category
Article
ISSN
0364-5134

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Enhanced sensitivity to N-methyl-D-aspar
Enhanced sensitivity to N-methyl-D-aspartate receptor activation in transgenic and knockin mouse models of Huntington's disease
✍ Michael S. Levine; Gloria J. Klapstein; Ahrin Koppel; Ehud Gruen; Carlos Cepeda; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 410 KB

We used two mouse models of Huntington's disease (HD) to examine changes in glutamate receptor sensitivity and striatal electrophysiology. One model, a transgenic, consisted of mice expressing exon 1 of the human HD gene and carrying 141-157 CAG repeat sequences (R6/2 line). The second model, a CAG

Cyclosporin A is effective, but not safe
Cyclosporin A is effective, but not safe, in the management of Behçet's disease
✍ B. Wechsler; E. B. Mertani; P. le Hoang; F. de Groc; J. C. Piette; H. Beaufils; 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB

1) recently reported the effectiveness and safety of cyclosporin A (CsA) treatment in patients with Behqet's disease. We have also used CsA in Behqet's disease patients and have noted similar degrees of effectiveness, but we have rather different findings with respect to renal tolerance. Of 150 pat